Clinical Trials Logo

Clinical Trial Summary

in this study, we are trying to monitor the effect of the addition of growth hormone on the different down regulation protocols ( long, short, antagonist and microflare). The outcome will be primarily assessed by the clinical pregnancy rates.


Clinical Trial Description

Poor responders undergoing IVF/ICSI cycles have emerged as a major problem. the need to find a proper stimulation protocol is a must. in this study we are trying to detect the best stimulation protocol ,in addition to growth hormone ,that can give the highest pregnancy rates in these patients. ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01897324
Study type Interventional
Source Woman's Health University Hospital, Egypt
Contact
Status Completed
Phase Phase 4
Start date July 2013
Completion date January 2015

See also
  Status Clinical Trial Phase
Completed NCT01915186 - Use of Dehydroepiandrosterone (DHEA) in Women With Normal and Poor Ovarian Reserve Undergoing IVF N/A
Withdrawn NCT02209168 - Differences in Ovarian Reserve Markers and Vitamin D Between Infertile Indian, Arabian and Caucasian Population
Completed NCT02341365 - Vitamin D Influence on Oocyte Donation N/A
Completed NCT02195947 - Antagonist Protocol in Poor Responders Phase 4
Completed NCT02185326 - Microflare Protocol in Poor Responders Phase 4
Recruiting NCT02294500 - Cohort Study to Evaluate Ovarian Function N/A
Recruiting NCT01662466 - Effect of Testosterone Treatment on Embryo Quality Phase 1/Phase 2
Enrolling by invitation NCT02179255 - Human Growth Hormone Pre-treatment for 6 Weeks Prior to Ovulation Induction for IVF Phase 1/Phase 2